PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsBreast cancer risk may still be higher despite BRCA-negative test results

BioNews

Breast cancer risk may still be higher despite BRCA-negative test results

Published 29 November 2013 posted in News and appears in BioNews 733

Author

Dr Charlotte Warren-Gash

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Women from families with a history of carrying the cancer risk gene BRCA2, but who test negative for it, may be at higher risk of breast cancer than previously thought...

Women from families with a history of carrying the cancer
risk gene BRCA2, but who test negative for it, may be at higher risk of breast
cancer than previously thought.

Professor Gareth Evans of the University of Manchester, the
lead author of the study, said it was 'likely that these women inherit genetic
factors other than BRCA-related genes that increase their breast cancer risk'.

The researchers analysed data from 807 families with a
history of carrying either the BRCA1 or BRCA2 gene mutation. Forty-nine women from
these families tested negative for their family-specific mutation but went on
to develop breast cancer.

The researchers noted four and a half times the number of breast cancers
in non-carrier women from BRCA2 families than would be expected in women of
the same age in the general population. However, the incidence of breast cancer in test-negative
women from BRCA1 families was not significantly increased.

Professor Evans suggests that families who carry BRCA2 may
be more likely to carry other cancer risk mutations.

'Around 77 single nucleotide polymorphisms (SNPs) are linked to breast cancer risk', he said. 'Identification
of additional SNPs is necessary to understand why some of the BRCA-negative
women from BRCA families are at higher risk'.

BRCA genes are 'tumour suppressor genes', encoding proteins that help the body repair damaged DNA. Inheriting faulty copies of these genes
allows genetic damage to accumulate in cells, which might potentially lead to
breast or ovarian cancer.

This new research may have implications for genetic counselling of women who test negative for BRCA2 mutations.

'Providing patients with
accurate information on their risk of developing breast cancer in the future is
critical for decision-making regarding different options and interventions', confirmed Dr Elisa Port, from the Dubin Breast
Center in New York, USA, speaking to HealthDay News.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 May 2015 • 2 minutes read

Genetic test results open to interpretation

by Dr Julia Hill

A report has warned that the interpretation of genetic tests often varies between labs and may result in incorrect clinical decisions being made...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
5 September 2014 • 2 minutes read

Study of Ashkenazi Jewish women suggests gene screening rethink

by Dr Charlotte Warren-Gash

All Ashkenazi Jewish women should be screened for high-cancer-risk genetic mutations) from age 30, say scientists behind a study looking at that population....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
5 September 2014 • 2 minutes read

Canadian cancer centre reports 'Angelina effect'

by Dr Kimberley Bryon-Dodd

Angelina Jolie's decision to openly discuss her preventative double mastectomy after testing positive for a dangerous BRCA1 mutation may have led to a dramatic upswing in referrals to genetic counselling services, if results from a Canadian study are widely applicable...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
8 August 2014 • 3 minutes read

Cancer risk genes: could PALB2 be BRCA3?

by Dr Kimberley Bryon-Dodd

A new study suggests that mutations in a gene called PALB2 are just behind BRCA1 and BRCA2 mutations as a leading genetic risk factor for breast cancer...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 June 2014 • 2 minutes read

Breast cancer gene raises lung cancer risk in smokers

by Dr Molly Godfrey

Smokers are more likely to develop lung cancer if they carry a defective version of a gene associated with breast cancer, a study has found...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
4 October 2013 • 2 minutes read

The Jolie effect: breast cancer gene testing increases, but so do surgery requests

by Ruth Retassie

A London clinic has reported an increase in the number of requests for BRCA genetic testing and preventative mastectomies since Angelina Jolie's announcement last May that she had undergone a double mastectomy....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
23 August 2013 • 3 minutes read

American health insurer will only pay for BRCA test after genetic counselling

by Simon Hazelwood-Smith

For the first time, a major health insurance company in the USA will require its customers to receive genetic counselling before it will pay for certain genetic tests...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 March 2013 • 3 minutes read

Patients should get health risk gene information whether they want it or not, says report

by Nina Chohan

The American College of Medical Genetics and Genomics has published a report recommending that patients who have their genomes sequenced should automatically be told of incidental genetic findings....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 January 2013 • 2 minutes read

Women with a family history of breast cancer should take preventative drugs, says NICE

by Dr Lux Fatimathas

Women at high risk of developing breast cancer should be offered preventative drugs, suggests the National Institute for Health and Clinical Excellence in updated guidelines...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Genetics and pesticide exposure 'double hit' might underlie Parkinson's for some

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

27 June 2022 • 2 minutes read

UK report reveals public attitudes to fertility, genomics and embryo research

27 June 2022 • 2 minutes read

Shortage of sperm donors despite men willing to donate

27 June 2022 • 2 minutes read

North East London CCG proposes offering three funded IVF cycles

27 June 2022 • 2 minutes read

Fibrosis drugs reverse ovarian ageing in mice

27 June 2022 • 2 minutes read

Gene implicated in motor neurone diseases discovered

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856